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1. Introduction 
Multidisciplinary approaches in tissue engineering and nanotechnology have resulted in the 
availability of new materials whose design and fabrication is inspired by the natural 
constituents of living organisms. This “bioinspired” approach of designing and 
manufacturing materials is referred to as biomimetism because materials made by this 
method exhibit the same structural and functional properties that are seen in naturally 
occurring biological materials. Thus in general terms, biomimetism or biomimetics as it is 
also called [Vincent 2003], can be defined as a two way path leading from biology to 
engineering and back, but in more scientific terms, biomimetic production of materials 
follows the principles and/or processes of biology to obtain end products that are useful for 
biological and non biological applications. Some examples of such successfully developed 
products are: (1) commercially important organic compounds that are made by in vitro 
replication of a specific in vivo metabolic pathway e.g. coloring agents - lycopene, ┚-
carotene, and astaxanthin [Dixon 2005, Chemler  & Koffas 2008] and anti-cancer drugs - 
paclitaxel, shikonin, geraniol [Chemler & Koffas 2008; Kolewe et al., 2008] (2) super-
hydrophobic and superadhesive glues that are manufactured by imitating processes similar 
to those seen in the lotus leaf, bee hive, gecko foot and rose petals  [Feng & Jiang, 2006; Feng 
et al., 2003; Nystrom et al., 2006, Nystrom et al., 2010, Lee et al., 2007; Kamino, 2008, Liu et 
al., 2010] (3) design of anti-fogging and antireflection coatings that are inspired by materials 
seen in mosquito eyes [Liu et al., 2010]. Along with these successful attempts there are also 
examples, where the application of biomimetic designing has so far not yielded the desired 
product. Engineering of Type I collagen is one such case where the natural target molecule 
exhibits divergent properties in different tissues ranging from the high Young’s modulus 
bearing substance in the matrix of the bone, to being the highly deformable elastomer in 
tendons, and exhibiting ideal optical properties in the multi-layered corneal tissue but it has 
not been possible to incorporate all these properties into a biomimetically produced collagen 
molecule [Weiner & Wagner, 1998, Meek & Fullwood, 2001].  
Most strategies in biomimetic material design and manufacturing involve the generation of 
hierarchical assemblies of multiple components; therefore the bioactive and self healing 
products that are thus obtained get referred to as “functional hybrids”. Although these 
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products are useful in diverse fields, such as the auto industry, computer logics and the 
wine industry, their main application is seen in the biomedical field – in particular 
manufacturing of biomedical devices for orthopedic applications. The design and 
manufacturing of orthopedic bimimetic implants is meant to replace parts of the hard  and 
weight-bearing bones [Rigo et al., 2004; Chakraborty et al., 2009; Kapoor et al., 2010; Nair et 
al., 2009; Geary et al., 2008] and replacing soft orthopedic tissue [Balasundaram & Webster, 
2007]. Further improvements in the implant’s properties, which could include the 
incorporation of bioactive molecules such as long chain proteins or short peptide sequences 
[Chakraborty et al., 2009; Kapoor et al., 2010; Balasundaram & Webster, 2007; Keselowsky et 
al., 2005; Le et al., 2006; Stevens et al., 2008; Sato &Webster, 2004], are necessary to make 
them more acceptable by the cells at the site and thus ensure their long term success. This is 
an ongoing process and several new developments have taken in this field in recent years. 
In this chapter we have focused on the anatomical organization of the orthopedic interfaces 
which are mimicked for tissue engineering applications and we have addressed some 
challenges that need to be met in the design and manufacturing of materials that can be 
used more effectively to replace damaged, malformed or diseased orthopedic tissue. 
2.0 Normal bone anatomy and functions: 
In order to efficiently biomimic the structure and function of bone components it is 
necessary to know the chemical biology and structural organization of the bone and its 
parts. Since the bone tissue contains uniquely large amounts of inorganic constituents along 
with the organic material, hence the details of how these two parts are biologically 
synthesized and combined are very important to be understood before efficient substitutes 
for them can be designed and manufactured.  
2.1 Gross anatomy of the human bones 
The simplest classification of the human bone subtypes is shown in Figure 1. It is interesting 
to note that a significant amount of tissue engineering work on making orthopedic devices 
has concentrated on the components of the long bones i.e. the 4 limbs of the appendicular 
skeleton. The internal organization and structure of the axial bones is much more complex 
than the tubular and cuboidal bones of the appendicular skeleton although the basic 
constituents of both types of bones are similar. Perhaps it is for this reason that the 
availability of biomimetically produced tissue engineered orthopedic products is 
significantly more for the appendicular bone parts than for the axial bone components with 
the possible exception of products related to teeth and intervertebral discs of the spine. 
Each long bone can be divided into three regions, namely the epiphysis, the metaphysis and 
the diaphysis (Figure 2). The epiphyses make the two rounded ends of the long bone which 
is supported underneath by the metaphysic layer. In adult bones the two layers encapsulate 
the growth plate or physis itself which is the main generator of osteogenic cells during the 
developmental phase. Both the metaphysis and epiphysis are composed of a soft trabecular 
(spongy) bone that is surrounded by a relatively thin shell of hard cortical bone. The 
diaphysis which is the hollow cylindrical shaft of the bone is made up of the dense cortical 
hard bone that surrounds the softer bone marrow area. The main length of the diaphysial 
hard bone area is lined by two thin connective tissue layers - the periosteum on the outside 
and endosteum on the inside. Most of the hard region of the bone which makes up the bone 
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Fig. 1. Classification of bones in the human skeletal system into axial skeleton (yellow color) 
and appendicular skeleton (green shaded areas). All the long (tubular) bones. e.g. femur, 
humerus, and short (cuboidal) bones e.g. carpals, tarsals etc. are in the  appendicular 
skeleton whereas the flat and irregular bones e.g. the vertebrae, the maxillofacial bones, 
bones of the skull etc. constitute the axial skeleton. 
 
 
Fig. 2. The gross structure of a long appendicular bone. The epi-physeal regions at the two 
ends of the bone comprise the softer part of the bone whereas diaphysis constitutes the hard 
part. The hard of the bone lies in the cortical region and it surrounds a softer part in the 
medullary region. The medullary region is lined by a membrane supported endosteal layer 
which acts like a stem cell generating niche. It also acts as the site to produce osteoclast cells 
which are main cells that take part in bone resorbtion. The periosteum lies as the outer 
covering the entire bone and is the site of osteoblasts and osteocytes to the cortical bone 
mass. 
Axial 
Appendicular 
Skeleton 
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mass and is responsible for its rigidity and load bearing capacity lies between these layers; it 
undergoes the maximum mineralization and therefore it contains the maximum inorganic 
content in the entire skeletal system. Due to their proximity with the bonemass the 
periosteum and the endosteum make up the two distinct orthopedic interfaces in long 
bones. They respectively play key roles in the formation and degeneration of the bone 
tissue. The cellular and biochemical organization of these two orthopedic interfaces along 
with the large mass of mineralised bone tissue that lies between them are the main targets of 
biomimetic designing and manufacturing products  for the human skeletal system. 
Structurally the periosteum is a vascularised membranous layer that covers the entire outer 
surface of all bones and functionally it acts as the regenerative orthopedic interface for the 
entire diaphysial region of the bone,. Externally it combines with the fibers and ligaments of 
the skeletal muscles and internally it provides attachment to the flattened osteoprogenitor 
cells which divide by mitosis and differentiate into osteoblasts and then osteocytes. The 
existence of the periosteum is essential for the regeneration of the bone after trauma injury. 
The endosteum, which makes the degenerative interface of the bonemass, lines the inner 
side of the mineralized cortical bone and has two surfaces - one which faces the outer 
mineralized side of the bone mass and another which faces the inner non mineralized 
sinusoidal bone marrow. The inner surface of endosteum makes several endosteal niches 
which harbor multipotent stem cells that generate hematopoietic, muscular, adipose and 
mesenchymal cell precursors in the marrow region. The outer surface of endosteum acts as 
the site for producing differentiated osteoclast cells that migrate into the mineralized bone 
matrix, between the periosteum and endosteum, and participate in its breakdown. 
Osteoclasts also remove the dead osteocytes that lie embedded in the matrix. The 
endosteum thus plays a key role in the bone remodeling by actively assisting the bone 
resorption process through osteoclasts. 
2.2 Histological and biochemical organization  
In general the bone tissue exhibits a unique histological organization, it exhibits the general 
properties of vertebrate connective tissues, but its matrix is uniquely dense, semi-rigid, 
porous and highly calcified because it is made up of an organic matrix and an inorganic 
mineral component. In a typical appendicular bone the matrix is composed of 
approximately 30-35% organic and 65-70% inorganic components. The organic component is 
called the osteoid which is composed of type I collagen and ground substances like 
glycoproteins, proteoglycans, peptides, carbohydrates and lipids. Mineralization of the 
osteoid, which can occur by several methods (see Section 3) constitutes the inorganic 
components of the bone and these constituents include calcium phosphate- hydroxyapatite 
Ca10(PO4)6(OH)2 and calcium carbonate along with similar salts of  magnesium, fluoride and 
sodium in lesser quantity [Clarke 2008; Kalfas 2001]. 
The cellular component of bone tissue comprises three main cell types: osteoblasts, 
osteocytes and the osteoclasts. As mentioned above osteoblasts line the periosteal layer and 
they are cuboidal to flat in shape. They secrete the unmineralized organic matrix which later 
mineralizes and leads to increase in organic component of bone matrix. Osteoblasts, as they 
migrate into the matrix or line the canaliculi the thin cylindrical spaces or canals seen in the 
bone mass, differentiate into osteocytes, which possess long thin cytoplasmic processes 
called the filopodia. The osteocyte lined canaliculi help in the passage of nutrients and 
oxygen between the blood vessels and matrix localized osteocytes. Osteocytes also break 
down the bone matrix by osteocytic osteolysis to release calcium for calcium homeostasis. 
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They also maintain extracellular phosphorus concentration. The third main category of cells in 
the bone mass are the osteoclasts. These are bone resorbing cells which are multinucleated and 
carry out the process of bone resorption. They are generated from the shallow depressions on 
the inner side of the endosteum called howship lacunae. A schematic representation of the 
cellular and inorganic organization of the bone mass is seen in Figure 3 below. 
 
 
 
Fig. 3. A figurative description of the cellular organization in two orthopedic interfaces the 
periosteum and the endosteum that surround the bone matrix in the hard cortical bone.  
3. Biomimicry of bone components  
The capacity of bone tissue components, both cellular and inorganic, to self-regenerate, 
particularly after trauma related injuries, has attracted the interest of many scientists [Alves et 
al., 2010]. During this regeneration process, we observe the recreation of mineral rich tissues of 
different constitutions and hence this process is also referred to as biomineralization [Palmer, 
2008]. Studying the process of biomineralization helps us in understanding the mechanisms by 
which living organisms deposit mineralized crystals within matrix [Sarikaya, 1999]. Among 
the approximately 40 different constituents found in the naturally formed biominerals, 
carbonates, phosphates and silicates of calcium are the most common [Stephen, 1988]. These 
salts have a significant role to play in determining the physiochemical properties and thermal 
stability in hard bone tissue [Sarikaya, 1999; Cai & Tang, 2009].  
In general terms, biomineralization process can be either biologically induced or biologically 
controlled. In biologically induced mineralization (BIM) the shape and organization of the 
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crystals is not directly under cellular control and it is determined entirely by inorganic 
processes. As a result of this the shape and organization of the inorganic compounds made 
by BIM is of a low order. In contrast to this biologically controlled mineralization (BCM) is 
cell dependent and it shows a well balanced organization of the mineralizing salts with the 
organic molecules resulting in well defined crystals of uniform shape, size and orientation 
[Khaner, 2007; Weiner & Addadi, 1997]. During post trauma osteo-regeneration both types 
of biomineralization processes are observed however the involvement of BCM is more 
dominant. Features common to bone mineralization are also seen in the biomineralization of 
many non skeletal tissues and cells and an examination of those properties helps in 
understanding the mechanism behind skeletal tissue mineralization. 
3.1 Non-skeletal biomineralization 
The biomineralization process in non skeletal cells and tissues generates very complex, 
diverse and interesting mineral forms and this process can be observed in almost in all 
organisms [Ozawa & Hoshki 2008; Veiss, 2005].  An evolutionary break through about this 
process was achieved in a report on the formation of magnetites in magnetotactic bacteria 
which indicated the commonality of biomineralization mechanisms in different biological 
forms and it also highlighted that this process is regulated by highly complex control 
systems  that are operational even in simple organisms. Several examples of non skeletal 
biomineralization in multicellular organisms are observed in nature along with the more 
common unicellular mineral producers. Some of these include silica spicule producing 
sponges, diatoms and actinopoda; synthesis of amorphous calcium carbonate in ascidians 
and formation of layered aragonite platelets in the nacreous layer of mollusk shells,few of 
such examples has been shown in Figure 4 below. [Sarikaya, 1999]. 
 
 
Fig. 4. Biologically controlled mineralization of hierarchical structures observed in A) 
magnetospirullum magnetium bacteria B) TEM of organic lattice of nacreous shell found in 
atrina C) finely organized enamel rod structures of mouse tooth D) ordered structures in 
siliceous skeleton lattice.[Atsushi et al., 2008; Yael et al.,2001;Sarikaya, 1999; James et al., 
2007] 
3.2 Biomineralization in skeletal tissue 
As indicated above, the biomineralization process in the bone tissue is different from what is 
exhibited by nonskeletal cells and tissues, because in skeletal cells it is primarily cell 
dependent i.e. it is controlled by BCM mechanisms. At the sub-cellular level 
biomineralization in bones is mediated by the formation of matrix vesicles (MV) which are 
membrane encased vesicles of size 20-200nm that are formed by a special exocytic membrane 
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budding process in polarized and differentiatiating osteoblasts/osteocytes of the long bones 
and also in the hypertrophic chondrocytes of the cartilage and odontoblasts of the growing 
teeth [Anderson, 2003]. After being secreted out of the cell, the MVs begin to deposit 
calcium phosphate/apatite crystals within the lumen of the vesicle itself or are specifically 
transported through the vesicular membrane into the matrix and they mineralize in 
conjunction with matrix collagen [Ciancaglini, 2006]. This process can thus be divided into 2 
phases - in phase I intra-luminal deposition of amorphous calcium phosphate, octa-calcium 
phosphates and HAp crystals is seen and in phase II seepage of HAp crystals occurs 
through the MV membrane into extracellular fluid resulting in nucleation of the crystals 
within collagen fibrils as calcified nodules [Guido & Isabelle, 2004; Kazuhiko et al, 2009]. 
Type-1 collagen acts as a template for initiating the crystallization of secreted calcium 
hydroxyapatite crystals [Vincet, 2008] which subsequently gets associated with other ECM 
components such as proteins, polysaccharides, proteolipids and proteoglycans to support 
activities such as cell adhesion, transport of ionic molecules, cell signaling etc. 
Understanding the steps of matrix biomineralization and its degeneration is therefore 
necessary in order to develop synthetic analogs that would mimic the matrix components 
that aid in the regeneration of new tissue [Joshua et al., 2009; Alves et al., 2010; Veiss, 2005]. 
3.3 Steps in bone modeling and remodeling 
As mentioned earlier and shown in Figure 3 the process of bone modeling and remodeling 
is a homeostatic process where the bone formation and resorption processes are observed 
simultaneously. The two processes are regulated by independent but related controls but 
since basic steps are very different from one another they need to be understood sperately in 
order to design materials to replace this integral component of the bone tissue. 
3.3.1 Bone modeling 
As mentioned above the bone modeling process in long bones is dependent mainly upon the 
calcification of the collagenous matrix of the bone mass. This process of physiological 
mineralization of collagen is controlled by the balance of enzymes, such as 
metalloproteinases, transporters, such as type III Na/Pi co-transporter, and channels, such 
as the annexin channels, which together aid to efficiently export the mineralizing molecules 
from the MVs into the matrix. In a recent study, using proteo-liposomal vesicles, it has been 
shown how to reconstruct a model that would mimic the MV microenvironment and would 
help us in better understanding the MV microenvironment [Simao et al., 2010]. In addition 
to the MV associated enzymes, transporters and channels some other molecules in the 
matrix such as tissue nonspecific alkaline phosphatase (TNAP), the group of docking 
proteins ankyrins and nucleotide associated inorganic phosphate, that influence the 
transport of MV pyrophosphate into the matrix and thereby regulate its calcification [Ellis,  
2009, Robert, 2001]. These matrix associated molecules exert their effects by directly 
controlling the amount of free inorganic phosphate in the ECM which in turns determines 
the transport PPi from the MVs [Ellis,  2009]. The effective role of matrix associated TNAP in 
controlling vesicle mineralization is highlighted in a disease named hypophosphatasia 
where TNAP activity is decreased because of a mutation in this gene the mobility of PPi 
from MVs to the matrix is very high [Robert, 2001]. Mineralization initiation in matrix 
vesicles is a function of several inhibitors, promoters that needs a proper balance between 
the elements that maintain them.   
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In addition to Type I collagen there are some other proteins in the matrix that also associate 
with the mineralized collagen and then further enhance or inhibit the mineralization 
process. Some of these proteins observed in bones and teeth are shown in Table 1. 
Osteopontin[OPN] and Bone Sialoprotein[BSP] are acidic proteins with high affinity for Ca2+ 
ions are localized within the collageneous matrix found adjacent to mineralization front that 
are involved in determining calcification. BSP are found to be initiator of mineralization 
whereas OPN affinity for apatite crystal founds to inhibit the crystal maturation process 
[Hunter et al ., 1996; Bernards et al., 2008].   
 
Bone Dentin Enamel 
Osteocalcin (OC) dentin matrix protein 1 
Enamelin 
 
Osteopontin (OPN) 
dentin sialo-phospho 
protein 
Matrix extracellular phospho-
glycoprotein (MEPE) 
Osteonectin (ON) - - 
Bone sialoprotein (BSP) - - 
Table 1. Major non-collageneous proteins that associate with mineralized ECM in different 
bone tissues 
3.3.2 Bone remodeling 
In contrast to the matrix modeling process the remodeling of the mineralized matrix is more 
complex because it can be controlled by many different mechanisms. In the case of normal 
bone homeostasis we observe a balance between the calcification and decalcification reactions 
in the bone matrix where the decalcification of the matrix is facilitated by the removal of the 
dead osteocytes and discharged MVs from the matrix. This process is primarily carried out by 
osteoclasts which arise from the endosteum. However, the decalcification process can be 
disturbed due to several reasons which could be either related to blockages or total stoppage 
of the calcification process or due to pathological changes in the tissue such as migration of 
cancer metastatic cells, activation of osteoporotic reactions etc.  
The modeling and remodeling of the matrix thus represent the two orthopedic interfaces of 
the bone which are generated at periosteum and endosteum respectively and their 
mineralizing and de-mineralizing functions overlap in the matrix as shown in Figure 3.  
4. Materials and methods for the mimicry of bone components 
Based upon the details of the natural processes that lead to mineralized bone formation and 
its degradation, as described above, there are several reports in the literature that describe 
strategies to generate materials in vitro that are similar to the in vivo physicochemical and/or 
biological properties of the bone components. In fact bone biomimetism remains as one of 
the most actively pursued and financially a very rewarding area of human tissue 
engineering. A brief summary describing the different types of materials and processes that 
are currently in use to generate bone like materials, for their use as bone implants or 
substitutes, is provided here. 
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4.1 Materials useful as substrates or modifiers in bone implants and/or bone 
substitutes 
The choice of materials that can be used to repair or replace a damaged or deformed bone is 
very wide. An overriding factor in choosing a base material for this purpose is its bioactivity 
and biocompatibility in vivo.  
 
Materials References 
Metals 
Stainless steel AISI 316L, Co–Cr–Mo 
alloy 
 
Ti and its alloys 
Ti6Al4V, TNZT alloys (Ti–Nb–Zr–Ta), 
Ni Ti, TiNbZr 
 
 
Ceramics and Bioglass 
┙-Al2O3, high alumina ceramics,    PSZ 
(partially stabilized   zirconia), 45S5 BG, 
S45P7 
 
Polymers 
Polyethylene (PE),  Polymethacrylic 
acid (PM MA), polyglycolic acid (PGA), 
poly lactic acid (PLA), polycarbonate 
(PC), polypropylene(PP) 
 
Composites 
Mg–Zn–Zr, HA-PEEK poly (aryl-ether-
ether-ketone), Polyphospha zenes, BG-
COL-HYA-PS (glass-collagen 
hyaluronic acid-phosphatidylserine) 
 
Yeung et al.,2007; Aksakal et al., 2008; Seligson  et 
al.,1997; 
Marti 2000 
 
Aksakal et al., 2008; Chakraborty et al., 2009; 
Yeung et al.,2007; Banerjee et al., 2004; Banerjee et 
al., 2006; Niinomi 2003; Ning et al., 2010; Seligson  
et al.,1997 
 
Kapoor et al., 2010; Christel et al., 1988; 
Gorustovich et al., 2010; Yuan et al., 2001 
 
 
 
Andersson et al., 2004; Reis et al., 2010; Oral et al., 
2007; Butler et al., 2001; Athanasiou et al., 1998; 
Smith et al.,2007; Geary et al., 2008; Shalumon et 
al., 2009; Jayabalan  et al., 2001 
 
 
Ye et al.,2010; Kurtz et al., 2007; Sethuraman et al., 
2010; Xu et al., 2010 
 
Table 2. A list of materials in use as base/substrate material in bone implants 
Since there is no material available that can per se become a bone substitute, several 
modifications on the original material are required to make it biocompatible. The aim to do 
these modifications is that the new material should be nontoxic and biologically inert but yet 
it should show orthopedic bioactivity and its production should be cost effective. The 
biocompatibility of the material is also dependent upon certain host factors such as general 
health, age, tissue perfusion and immunological factors [Wooley et al., 2001] and therefore 
only certain types of materials have been used so far for this purpose. A list of such 
materials currently in use is given in Table 2. 
Each of the listed materials in the Table has some unique quality that qualifies it to be used 
as the base material or the substrate of an orthopedic implant. Cationic metals for example 
can form ionic bonds with non-metals and can be easily converted into alloys which have 
good ductile properties and heavy load bearing strength. Among the nonmetals, ceramics 
are interesting because their inter-atomic bonds are either totally ionic or predominantly 
www.intechopen.com
 Advances in Biomimetics 
 
382 
ionic and they can be covalently bonded to a number of compounds including proteins. 
Among the polymers for orthopedic use, plastics and elastomers have been the main choice 
but because of their limited weight bearing capacities their use is restricted. The composites 
are useful because they can combine the properties of two or more compounds making it a 
more versatile material to get a functional hierarchy of substances needed to make a bone 
like substance. 
Besides the substances which are used as substrates for making biocompatible materials, 
there are many other unique elements of bone structure which lend themselves to be 
mimicked by manmade materials as functionalizing compounds of the substrates. One of 
the most commonly mimicked biomaterial for this purpose is  apatite which is the most 
abundant phosphate mineral on earth found in mineralizing vertebrates. Among all the 
calcium phosphate minerals available hydroxyapatite (HAp) is found to be the most 
thermodynamically stable bioceramic material at physiological environment which helps in 
faster osteointegration. Hence the most sought after properties that material scientists and bone 
tissue engineers look for in their apatite are bone bonding ability and osteo-conductivity in 
addition to their general biocompatibility and bioactivity. The starting compounds used for 
making HAp is generally calcium phosphate and based on some solution parameters like 
super saturation, other ionic products and pH we can get many other apatite phases apart 
from HAp. These non-naturally occurring apatite phases can be more useful than naturally 
occurring ones.  
 
MINERAL NAME Ca/P ratio Abbreviation 
Monocalcium  phosphate monohydrate 0.5 MCPM 
Monocalcium phosphate:dihydrate 0.5 MCPD 
Dicalcium phosphate: dehydrate mineral brushite 1.0 (DCPD) 
Anhydride mineral monetite 1.0 (DCPA) 
Octacalcium phosphate 1.33 (OCP) 
┙-tricalcium phosphate 1.5 (┙TCP) 
┚-tricalcium phosphate 1.5 (┚-TCP) 
Whitelock mineral 1.29  
Hydroxyapatite  O- HAp 1.67 OHAp 
Calcium-deficient hydroxyapatite 1.5-1.67 (CDHA) 
Fluorapatite 1.67 (FAp) 
Chloroapatite 1.67 (ClAp) 
Carbonated apatite TYPE A 1.67 (CO3Ap) 
Tetracalcium phosphate, mineral hilgenstokite 
2.0 
(TTKP or 
tetcp) 
Table 3. Different types of calcium phosphates obtained during preparation of HAp 
A list of the various types of apatite phase that can be obtained from different calcium 
phosphates is given in Table3. Besides using calcium phosphate, a combination of various 
salts is also used to generate HAp. This process is more close to the natural process because 
the constituents of starting material are based upon the constituents of the natural body 
fluid such as blood plasma. The solution that most represents the similarity with blood 
plasma is referred to as simulated body fluid or SBF and its many constituents have been 
described elsewhere Tadashi and Hiroaki 2006 and Jalota et al 2006.  
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 Na+ K+ Ca2+ Mg2+ HCO3- Cl- HPO42- SO4 2- Ca/P Ph 
Blood Plasma 142 5 2.5 1.5 27 103 1 0.5 2.5 7.4 
SBF Range 
127-
734 
5-10
2.5-
12.5
1.5-
7.5 
4.2-35 111-724 1-5 0.05-1 0-2.5 7.25-7.4 
TYPE-1 142 5 2.5 1.5 4.2 148 1.8 ---- 1.4 7.25 
TYPE-2 142 5 2.5 1.5 27 147.8 1 0.5 2.5 7.4 
TYPE-3 
c-SBF2 
c-SBF3    
SBF-JL1  
SBF-JL2
142 
142 
142 
142 
5 
5 
--- 
2.5
2.5
2.5
- 
1.5 
1.5 
- 
- 
4.2 
35.23 
34.9 
34.88 
147.96
117.62
111 
109.9 
1 
1 
1 
1.39 
0.5 
0.5 
- 
- 
2.5 
2.5 
2.5 
0 
7.4 
TYPE-4 
SBF 
d-SBF 
142 
142 
5 
5 
2.5
1.6
1.5 
0.7 
4. 2 
4.2 
147.8 
144.1 
1 
1 
0.5 
0.5 
2.5 
1.6 
7.25 
7.25 
TYPE-5 142 5 2.5 1.5 4.2 148 1 0.5 2.5 7.4 
TYPE-6 
 
 
SBF 
5XSBF 
142 
714.8
5 
----
2.5
12.5
1.5 
7.5 
4.2 
21 
147.8 
723.8 
1 
5 
0.5 
---- 
2.5 
2.5 
7.4 
7.6 
TYPE-7 127 10 12.5 3 35 123 5 ---- 2.5 7.4 
 
TYPE-8 142 5 2.5 1.5 4.2 147.8 1 0.05 2.5 7.4 
TYPE-9 SBF-1 
5XSBF 
SBF-2 
142 
213 
142
5 
7.5
5 
2.5
3.8
2.5
1.5 
2.3 
1.5 
4.2 
6.3 
4.2 
148 
223 
148.8 
1 
1.5 
1 
0.5 
0.75 
0.5 
2.5 
2.53 
2.5 
7.4 
TYPE 
10 
SBF-a 
SBF-b 
714.8
704.2
----
----
12.5
12.5
7.5 
1.5 
21 
10.5 
723.8 
711.8 
5 
5 
- 
- 
2.5 
2.5 
7.4 
TYPE-11 142 5 2.5 1.5 4.2 148.8 1 0.5 2.5 7.4 
TYPE-12 142 5 2.05 1.5 4.2 148 1  2.05 7.4 
TYPE-13 142 5 2.5 1.5 4.2 148.5 1 0.5 2.5 7.4 
TYPE-
14 
1XSBF 
3CaP 
SBF 
142 
109.5
5 
6 
2.5
7.5
1.5 
1.5 
4.2 
17.5 
147.8 
110 
1 
3 
0.5 
- 
2.5 
2.5 
7.5 
TYPE-
15 
SBF(N)    
SBF(O) 
142 
142 
5 
5 
2.5
2.5
1.5 
- 
27 
- 
123 
123 
1 
1 
0.5 
0.5 
2.5 
2.5 
7.2 
TYPE-16 109.5 6 7.5 1.5 17.5 110 3 0  
6.65-6.71 
6.55-6.65 
6.24-6.42 
Table 4. Recipes for making different types of Simulated Body Fluids for biomimetic 
preparation of Apatite 
[Reference for the above Table are a-Liu et al.,1998; b-Kokubo & Kim, 2004; c-Marc & 
Jacques,2009; d-Chikara et al., 2007; e-Kokubo,1996; f-Bharati et al.,2005; g-Qu & Mei,2008; h-
De Medeiros et al., 2008; i-Tsai et al.,2008; j-Habibovic et al.,2002; k-Hyun et al.,1996;  l-Silvia 
et al.,2006; m-Xin et al.,2007; n-Yajing et al.,2009; o-Kapoor et al.,2010; p-Haibo & Mei 2008] 
Over the years the constitution of SBF has undergone so many modifications that would 
be compiled into a list of different SBFs that can used to obtain bone like apatite for bone 
remodeling purposes. This compilation is shown in Table 4. The original SBF was 
intended to study mainly the bone-bonding ability of the apatite and it lacked in sulfate 
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ions in relation to original plasma constituents. The SBF constitution was later upgraded 
with major variations done in chlorine and bicarbonate compositions and to a lesser 
extent in sulphate ions. SBF with higher Cl- and lower HCO3- concentrations and 
variations in buffer systems and pH are found to be in equilibrium with the blood plasma. 
The physiological pH is maintained in this in vitro system using tris (hydroxymethyl) 
amino methane (Tris)/HCl. 
4.2 Methods for preparing substrates and modifier materials 
While the base substrate materials are prepared by conventional metallurgical methods, 
their bioactivity is induced by functionalizing them with many modifier materials. The 
modifier materials include proteins, enzymes and most importantly the different types of 
apatites. There is an endless list of techniques by which apatite deposition can be carried 
out on orthopedically selected substrates, but the successful methods are those which give 
high bone bonding ability and good osseointegration. Among the different available 
techniques, plasma spray, sol-gel synthesis and biomimetic methods are the most 
successful. Some salient features of the first two and details of the biomimetic approaches 
are provided here. 
4.2.1 Plasma spray 
Plasma spray coatings on to metal substrates have gained interest during the past decades 
due to its high deposition rate and its large scale efficiency. This method is compatible with 
various platforms including ceramic composites apart from metals. Numerous studies have 
been carried out on the bone bonding behavior of these coatings with the substrates. The 
thickness of the coating is of few microns size. The precursor is mainly fed in the form of 
powder which is released into a plasma gun. A high voltage argon gas generates plasma 
where the powder gets partly melted and is directed towards the substrate followed by 
rapid cooling further impelling the substrate thus depositing a coat. This method has been 
used to deposit different functionalized materials on either metal or non-metal surfaces. 
[Chen et al., 2008; Chen et al., 2006; Culha et al., 2010] 
But the major concerns regarding this process a) is the instability of the coatings therefore poor 
binding of the coating with the substrate or implant .This necessitates them for further 
processing to increase the mechanical interlocking of the coating-substrate system. b) High 
processing temperatures involved lead to changes in CaP phases resulting in the formation of 
less stable phases thereby reducing the bonding strength between the substrate and the 
coating. c) These coatings are largely amorphous with less homogeneity over the entire 
substrate resulting in structures of low crystallinity which signifies that the substrates are not 
bioactive enough to induce the required bone attachment. Many functionalized scaffolds have 
been developed by this technique and there biocompatibility was checked in-vivo so that these 
implants can be used for various orthopedic applications [Heimann et al., 2004; Wu et al., 2009] 
4.2.2 Sol-gel synthesis 
This technique is one of the oldest in developing thin film coating having varied 
applications like protective coatings, passivation layers, sensors and membranes. The 
methodology involves the fabrication of materials by using a chemical solution (sol) which 
acts as the precursor for a specialized integrated network (gel) of either particles or network 
oligomers/polymers. The unique property of this method is that the kinetics of the reaction 
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can be controlled by monitoring the particle size, porosity and thickness of coating. Hence 
the fabricated materials can be obtained in the form of films, powders, fibers, processed at a 
lower temperature which differentiates it form the conventional processing strategies 
[Podbielska and Ulatowska-arza 2005].  
The starting materials used are inorganic or metal-organic precursors (alkoxides). The 
chemistry of this process involves basically two reactions like hydrolysis and 
polycondensation. When metal- alkoxides are used the alkoxide is dissolved in alcohol and 
hydrolyzed by the addition of water, whereas in case of metalloids, acid or base catalyst is 
added which replaces the alkoxide ligands with hydroxyl groups. In case of inorganic 
precursors like salts, hydrolysis proceeds by the removal of a proton to form a hydroxo (-
OH) or oxo (=O) ligand. Therefore subsequent condensation reactions in case or organic and 
inorganic produces oligomers or polymers composed of M-O-M or M-µ(OH)-M bonds.  
The coating is generally done by depositing the precursor on to the substrate either by dip 
coating or spin coating, later the samples are dried at high temperature which results in 
shrinkage and also increases the density of the deposited precursors. The coating thickness 
is a function of withdrawal speed, concentration and viscosity of the solution hence the 
porosity of the gel is dependent on the rate at which the solvent is removed. The simplicity 
of this procedure develops uniform coatings of high homogeneity [Klein, 1988].Many 
biocompatible, bioactive and stable metals/non-metals and bioglass scaffolds are deveopled 
by this technique by depositing HAp, various bioactive proteins in the form of thin films 
and nanoparticles[Weng et al., 2003; Wang etal.,2008; Vijayalakshmi et al.,2008] for hard and 
soft tissue replacement[Kim et al.,2005; Nguyen et al.,2004; Sepulveda et al.,2002; Zheng et 
al.,2009]. 
4.2.3 Biomimetic process 
Since the theory of biomimetic process proposed by Kokubo, the study of bioactivity using 
SBF has been reviewed by many research groups all these years. Why these studies are at a 
faster pace and what makes this process so challenging from other technologies in 
predicting bone bioactivity in vivo. This process aims at mimicking the blood plasma 
compositions in acellular conditions using SBF [Tadashi & Hiroaki, 2006]. For natural bone 
to bond with the implants there must be specific appropriate response which it feels that it 
can be accepted, is mainly achieved by depositing apatite on to these surfaces termed as 
bioactivity/bone-bonding ability. Bones ability to deposit calcium phosphate defines its 
characteristic property as a hard connective tissue. Several results have been obtained using 
this procedure and they have been summarized in Table 6. 
Bio-mimetic Coating Method used to Functionalize Ti-6Al-4V and α-Al2O3 
Our lab is also developing functionalized scaffolds which can be in long run used for bone 
engineering applications. 
We are working with metal (Ti and its alloys like (Ti-6Al-4V, TiZr, and TiNb), non-metals 
(Ceramic like ┙-Al2O3) and glass, functionalizing them in order to check the cell behavior in 
vitro and also check there bio-compatibility properties in vivo. 
There are many methods to functionalize the metal/non-metal surface by using 
HAp/calcium phosphate which can be done by various methods like plasma spray method, 
sol-gel coating method, dip coating methods but the most easy and efficient way to mimic 
the natural component of bone is by Biomimetic coating method, hence we have utilized this 
process to develop an even, functionalized HAp coating on a titanium alloy (Ti-6Al-4V) and  
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Cell culture studies 
and  materials used 
Objectives Results References 
Apatite and apatite/ 
collagen composite 
coatings on PLLA 
using Saos-2 
osteoblast like cells 
Cell attachment,  
proliferation and 
differentiation 
Biomimetic apatite/collagen 
coating found to exhibit 
higher proliferation and 
differentiation in comparison 
to apatite coatings 
Chen et al., 
2008 
Biomimetic and 
electrolyti -cally 
deposited carbonate 
apatite on Ti alloy 
using MC3T3-E1 
cells. 
Cellular 
proliferation and 
differentiation  
Higher proliferation and OC 
and BSP mRNA expression 
on biomimetically coated 
substrates than 
electrolytically deposited 
method.  
Jiawei et al., 
2009 
Chemically 
pretreated CP Ti 
immersed in SBF for 
2 and 14 days and 
tested using human 
osteoblasts (MG-63) 
cells. 
Cell spreading, 
proliferation and 
differentiation 
A well spread morphology 
was observed both 
functionalized surfaces. TiCT 
and TiHCA surfaces 
rendered increased 
expression of collagen 1 and 
ALP at 7 and 14 days. 
Barbara et al 
., 2008 
HA deposition on 
negatively charged 
SAM coated glass  
cover slips by 
culturing human 
mature OC of bone 
cell tumor for 24hrs 
Osteoclastic 
activity through  
F-Actin ring 
formation,  
calcium release  
and formation of  
resorption pits 
Osteoclast were able to attach 
and resorb on coated glass 
cover slips 
Asiri et al., 
2009 
Biomimetic apatite 
deposition on  
hyaluronic acid 
(HA)-based polymer 
scaffold  
Osteogenic 
induction of 
mesenchymal 
stromal cells (h-
MSCs) 
At higher mineralization on 
HA-based scaffold. 
Cristina et al 
., 2010 
Incorporation of 
bisphosph -onate 
sodium clondrate  
into biomimetically 
coated apatite on to 
starch based scaffold 
using human 
osteoblast-like cell 
line (SaOs-2) 
Effect of BP on 
osteoclastic 
activity and cell 
morphology, 
attachment and 
proliferation  
Osteoblastic activity was 
simulated with 
bisphopshonates at dose 
dependent concentration of 
0.32mg/ml by enhanced cell 
viability 
Oliveira et 
al., 2010 
BMP-2 into 
biomimetic apatite 
coatings using  Rat 
bone marrow 
stromal cells for 
8days on Ti implants 
Osteogenic 
activity 
Protein incorporated CaP 
coatings enhanced the 
alkaline phophatase activity 
Yuelian et 
al., 2004 
Table 6. Cellular responses to biomimetically prepared substrates and coatings 
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on a bioinert ceramic substrate (┙-Al2O3). In our method, the metal /ceramic substrates were 
incubated in simulated body fluid (SBF) at 25°C for different time points with prior 
treatment with globular protein BSA (bovine serum albumin) [Chakraborty et al., 2009; 
Kapoor et al., 2010]. This process leads to the formation of HAp coating exhibiting bone like 
apatite growth on the surface. It may further be noted that bone, a natural composite 
comprises non stoichiometric calcium hydroxyapatite (HAp) precipitated in a controlled 
reaction environment of a highly aligned, anisotropic organic template. It differs from 
stoichiometric hydroxyapatite (HA) in composition, crystallinity and other physical and 
mechanical properties developed artificially through various methods. 
The surface treatment and coating of these materials had shown a better cellular response in 
vitro and also a good biocompatibility property in vivo when compared with untreated and 
uncoated materials. The surface treatment by globular protein i.e., BSA might provide a 
functionalized template comprising of charged amino-acids which resulted in more 
nucleation sites [Chakraborty et al., 2009] hence led to the even coverage of HAp (about 280-
300µm) by immersion of the materials in SBF at desired temperature of 25°C between the 
pH range of 5-7, which resulted in the formation 30-40 nm albumin globules, under 
specified conditions, on both ceramic and Ti-6Al-4V alloy substrates. In comparison with the 
untreated substrates the coverage of HAp was very much poor(less than 200µm), hence BSA 
treatment has led to the development of nano-sized globules after HAp coating which have 
led to the better cellular-activity in-vitro which is due to “cooperativity” reaction 
[Chakraborty et al., 2009] between protein molecules and the charged surface of HAp, 
depending on the concentration of the protein molecules in the coating [SBF] solutions.   
We have done a comparative study of biological properties of the unique coating of HAp 
developed on both metal and non-metal which is less reported. Based on the methodology 
of functionalizing these materials we have generated many substrates of Ti and Ceramic 
which showed a different structural variation and these specific morphological structures of 
protein and HAp has led to good fibroblast [NIH-3T3] cell response. The Ti-6Al-4V which is 
BSA treated and coated for 4 days has shown a nano-sized globules (as indicated by arrows) 
due to globular protein treatment has shown a better in-vitro and in-vivo activity which can 
be seen in Figure 1 panel c in comparison with the bare Ti-6Al-4V panel a, BSA treated Ti-
6Al-4V panel b and coated Ti-6Al-4V for 4 days without prior treatment with BSA panel d 
which did not show nano-sized HAp globules. 
The unique structural property of HAp coating on Ti-6Al-4V treated with BSA and coated 
for 4 days is shown in Figure 2 where panel a shows the inter and intra connection of HAp 
fibers into plates which can be seen in higher magnification in panel b. Panel c shows the 
femur bone like growth of HAp fibers [Kapoor et al., 2010] which represents the unique 
methodology in mimicking the bone like components by generating a highly functionalized 
scaffold for in-vivo applications. 
On the contrary, micron sized globules of HAp [Figure. 3(c)] were observed on the BSA 
treated and coated for 2days ceramic substrate surface. This may be attributed to the 
enhanced hydrophilicity of the BSA treated ceramic substrate (it already has intrinsic 
hydrophilicity) that accumulates –OH groups throughout the mechanically roughened (grit 
blasted) surface, on immersion in simulated body fluid (SBF), aqueous medium. These act as 
nucleation sites and induce Ca2+ ions from SBF to be coordinated to the above –OH groups 
on the substrate, by electrostatic force of attraction. Hence nucleation of a large number of 
HAp globules takes place and they grow fast into micron sized globules owing to the high 
surface energy as mentioned, resulting in a dense coverage of substrate surface. Hence due 
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to large deposition of micron-sized HAp globules the NIH-3T3 cellular response was much 
better on this ceramic substrate in comparison to the bare ceramic (panel a), BSA treated 
ceramic(panel b) and untreated and coated for 2 days panel d which showed a much bigger 
HAp deposition. 
 
Fig. 4. SEM images of different Ti-6Al-4V where (a)Bare Ti-6Al-4V (b)BSA Treated Ti-6Al-4V 
(c)BSA Treated and Coated for 4 days  Ti-6Al-4V (d) Coated for 4 days  Ti-6Al-4V.( Image 
generated from Kapoor et al., 2010). 
 
 
Fig. 5. SEM Images of Ti-6Al-4V substrate which is BSA treated and coated for 4 days where 
(a) Inter- and intraconnection of the HAp fiber in the crystal plates of 4-day coated substrate. 
(b) Higher-magnification image of B showing the fiber merges into the crystal plates of the 
HAp coating. (c) Femur bone-like structure obtained in B4. (Image generated from 
Chakraborty et al., 2009). 
 
 
Fig. 6. SEM images of ┙-Al2O3 where (a)Bare ┙-Al2O3 (b)BSA Treated ┙-Al2O3 (c)BSA Treated 
and Coated for 2 days  ┙-Al2O3 (d) Coated for 2 days  ┙-Al2O3.( Image generated from 
Kapoor et al., 2010).  
Our in vivo experiments also proven that metal/nonmetal implants which are protein 
treated and coated are more bioactive as they showed no negative response in term of any 
kind of inflammatory responses. 
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This comparative assessment of metal/non-metals structural and biological properties 
showed that metal when treated with protein and biomimtically coated for HAp can be 
used as a scaffold for many biomedical applications especially for osteoconduction. In 
modification for the method proposed, many biologically active molecules like osteogenic 
agents and growth factors can be co-precipitated with apatite crystals onto metal implants 
for the better osteogenic behavior as this biomimetic coating can be readily absorbed in-
vivo. 
5. Orthopedic challenges 
As new methodologies for making functional components of human tissues to rectify a 
deformity or for developing new treatments of disease and trauma get developed we realize 
the limitations of the techniques and principles of biomimetic tissue engineering in facing 
up the real challenges of this approach. While many new methodologies have become 
available for the management of orthopedic disease and trauma, the computability of the 
manmade materials in this area is far from ideal. We describe here some of the unmet 
challenges of this field.  
5.1 Biocompatibility and stability of in-vivo scaffolds 
One of the most important aims of biomimetic design and production of materials for bone 
implants is to make them stable and compatible to the local bone tissue. Since there is 
considerable diversity in the details of local anatomies of specific bones the presently 
available general implant materials are prone to infection, extensive inflammation, and poor 
osteointegration. Besides their life span is less than 15 years which clearly shows the 
inability to mimic the longetivity of the molecular components of bone [Harold 2006, Porter 
2009]. The implant failure is mainly attributed to acute complications, host responses, 
prosthesis dislocations and surgery failures seen at initial stages after surgery, and also after 
several years post surgery when implant loosening, osteolysis, implant wear and tear, 
instability, infection and fractures are observed. 
In order to increase implant life it would be advisable to seed them with young osteoblasts 
which would sustain the production of bone mass on the implants (Xynos et al., 2001). It 
would also be useful to use bioactive agents in the coatings that would activate pathways 
related to cell survival, proliferation and differentiation. Thus it is clear that in order to 
increase the life of the implanted material it would be advisable to shift the focus of material 
production from a purely material science outlook to a cell biological and molecular 
biological approach. 
5.2 Materials for osteoporotic applications 
Osteoporosis a major health threat to bone degenerations due to decreased bone quality, are 
characterized by reduction in bone mass and disordered skeletal micro-architecture and  are 
susceptible to fracture risks at sites of hip, spine and wrist [Borges & Bilezikian, 2006]. Much 
of the concerns regarding this are found in older populations where treatment becomes 
possible to an extent through regular controlled diet activities. Since the loss in bone mass 
can be directly attributed to the abnormal remodeling process therefore biomimetic tissue 
engineering approaches could offer alternate approaches to reduce the hyperactive bone 
resorption process. One of the targets for this could be the receptor for nuclear factor kappa 
B which seems to be involved in osteoblast–osteoclast coupling mechanisms. 
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6. Conclusion 
We have shown in this chapter how one can use biomimetic approaches to simulate the 
osteoregenerative (periosteal surface) and osteo-degenerative (endosteal surface) interfaces 
of appendicular bones. These processes include novel tissue engineering strategies that 
combine developments in the field of material science  with the cell and molecular biological 
pathways that are seen in the natural differentiation of osteoblast and osteoclast. We hope 
that some of these strategies would lead to the better management of trauma and age related 
degeneration of bone tissues. 
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